CBD Helps With This Rare Blistering Skin Disorder, New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa Treatment
CBD Helps With This Rare Blistering Skin Disorder, New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa Treatment
There is no cure for a rare blistering skin disorder called Epidermolysis Bullosa (EB), but treatments to help alleviate and control the symptoms do exist.
一種名爲大皰性表皮鬆解症（EB）的罕見水皰性皮膚病尚無治癒方法，但確實存在幫助緩解和控制症狀的治療方法。
The growing body of research suggests cannabinoid-based medicines can ease the pain and severe itching in those with this disorder while also improving healing.
越來越多的研究表明，基於大麻素的藥物可以緩解這種疾病患者的疼痛和劇烈瘙癢，同時還可以改善癒合效果。
Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN), a biopharma company focused on the development and commercialization of plant-derived CBD products announced it has completed a retrospective observational real-world study using its RHO Phyto branded Ultra CBD Topical Cream, an oil-based 3% CBD localized cream on patients with epidermolysis bullosa.
專注於植物衍生CBD產品開發和商業化的生物製藥公司Avicanna Inc.（多倫多證券交易所股票代碼：AVCN）（OTCQX：AVCNF）（FSE：0NN）宣佈已使用其RHO Phyto品牌Ultra CBD外用霜完成了一項回顧性觀察性現實世界研究，這是一種針對大皰性表皮鬆解症患者的油基3％CBD局部乳膏。
See also: Game-Changer In Epidermolysis Bullosa Treatment? Cannabis Compound Holds Promise
另見：大皰性表皮鬆解症治療的遊戲規則改變者？大麻化合物前景光明
Led by Elena Pope, MD, M.Sc., FRCPC, head of dermatology at The Hospital for Sick Children in Toronto, the study evaluated the reported and documented responses related to wound healing, pain and itch end points through images for study purposes.
該研究由多倫多兒童病醫院皮膚科主任、醫學博士、理學碩士、FRCPC Elena Pope領導，通過圖像評估了報告和記錄的與傷口癒合、疼痛和瘙癢終點相關的反應，用於研究目的。
The research included 20 patients with an average age of 17.3 years, including 6 female and 14 male patients. All patients were diagnosed with various subtypes of EB including dystrophic (60%), simplex (30%) and junctional (10%).
該研究包括20名平均年齡爲17.3歲的患者，其中包括6名女性和14名男性患者。所有患者都被診斷出患有各種亞型的EB，包括營養不良（60%）、單純性（30%）和交界性（10%）。
Results
結果
The study findings showed that following a month-long application of the 3% CBD cream daily, 55% of patients reported improvement in wound healing while 45% displayed wound stability.
研究結果表明，在每天使用3％的CBD乳膏長達一個月後，有55％的患者報告傷口癒合得到改善，而45％的患者表現出傷口穩定性。
Moreover, self-reported itch and pain scores were reported in 65% and 50% of patients, respectively.
此外，65％和50％的患者分別報告了自我報告的瘙癢和疼痛分數。
"The use of RHO Phyto branded Ultra CBD Topical Cream is a novel topical therapeutic option for EB patients, providing symptom relief and potentially aiding in wound healing with good tolerability," Dr. Pope said in a press release. "Further prospective studies are needed to substantiate these findings."
波普博士在一份新聞稿中說：“使用RHO Phyto品牌的Ultra CBD外用藥膏是EB患者的一種新的局部治療選擇，它可以緩解症狀，並有可能以良好的耐受性幫助傷口癒合。”“需要進一步的前瞻性研究來證實這些發現。”
Interested in learning more about cannabis innovation? Join us at the 19th Benzinga Cannabis Capital Conference in Chicago this Oct. 8-9. Get your tickets now before prices go up by following this link.
有興趣進一步了解大麻創新的嗎？加入我們，參加將於10月8日至9日在芝加哥舉行的第19屆Benzinga大麻資本會議。點擊此鏈接，立即在價格上漲之前獲取門票。
譯文內容由第三人軟體翻譯。